A randomized, controlled trial of NRT-aided gradual vs. abrupt cessation in smokers actively trying to quit
- PMID: 20537810
- PMCID: PMC2930079
- DOI: 10.1016/j.drugalcdep.2010.04.007
A randomized, controlled trial of NRT-aided gradual vs. abrupt cessation in smokers actively trying to quit
Abstract
Most smoking cessation programs advise abrupt rather than gradual cessation. We conducted a randomized, controlled trial of gradual cessation (n=297) vs. abrupt cessation (n=299) vs. minimal treatment (n=150) among smokers who wanted to quit now and preferred to quit gradually. Participants were recruited via newspaper and radio advertisements. The gradual and abrupt conditions received five phone calls (total=90 min) and the minimal treatment condition received two calls (25 min total). The gradual condition received nicotine lozenge (via mail) to reduce smoking prior to their quit date. After the quit day, all participants received lozenge. The primary outcome was prolonged abstinence from 2 weeks post-quit day through 6 months. Prior to the quit day, the gradual condition decreased cigarettes/day by 54%, whereas the other two conditions decreased by 1% and 5%. Prolonged abstinence rates (CO<10 ppm) did not differ among gradual, abrupt and minimal treatment conditions (4%, 7% and 5%), nor did 7-day point prevalence rates (7%, 11% and 11%). Fewer smokers in the gradual condition (48%) made a quit attempt than in the abrupt (64%) or minimal (60%) conditions (p<.001). In the gradual condition, every week delay to the quit date increased the probability of lapsing by 19% (p<.001). We conclude that among smokers who want to stop gradually in the near future, gradual cessation with nicotine pre-treatment does not produce higher quit rates than abrupt cessation. One liability of gradual reduction may be that it allows smokers to delay their quit date.
Trial registration: ClinicalTrials.gov NCT00297492.
Copyright 2010 Elsevier Ireland Ltd. All rights reserved.
Figures



Similar articles
-
Is delaying a quit attempt associated with less success?Nicotine Tob Res. 2011 Dec;13(12):1228-32. doi: 10.1093/ntr/ntr207. Epub 2011 Sep 8. Nicotine Tob Res. 2011. PMID: 21908460 Free PMC article. Clinical Trial.
-
Smoking reduction interventions for smoking cessation.Cochrane Database Syst Rev. 2019 Sep 30;9(9):CD013183. doi: 10.1002/14651858.CD013183.pub2. Cochrane Database Syst Rev. 2019. PMID: 31565800 Free PMC article.
-
Impact of messages on concomitant use of nicotine replacement therapy and cigarettes: a randomized trial on the Internet.Addiction. 2003 Jul;98(7):941-50. doi: 10.1046/j.1360-0443.2003.00406.x. Addiction. 2003. PMID: 12814500 Clinical Trial.
-
Different doses, durations and modes of delivery of nicotine replacement therapy for smoking cessation.Cochrane Database Syst Rev. 2019 Apr 18;4(4):CD013308. doi: 10.1002/14651858.CD013308. Cochrane Database Syst Rev. 2019. Update in: Cochrane Database Syst Rev. 2023 Jun 19;6:CD013308. doi: 10.1002/14651858.CD013308.pub2. PMID: 30997928 Free PMC article. Updated.
-
Gradual Versus Abrupt Smoking Cessation: A Randomized, Controlled Noninferiority Trial.Ann Intern Med. 2016 May 3;164(9):585-92. doi: 10.7326/M14-2805. Epub 2016 Mar 15. Ann Intern Med. 2016. PMID: 26975007 Clinical Trial.
Cited by
-
Pharmacological interventions for the treatment of smokeless tobacco use.CNS Drugs. 2012 Jan 1;26(1):1-10. doi: 10.2165/11598450-000000000-00000. CNS Drugs. 2012. PMID: 22136150 Review.
-
Varenicline for Gradual Versus Abrupt Smoking Cessation in Poorly Motivated Smokers With COPD: A Prematurely Terminated Randomized Controlled Trial.Chronic Obstr Pulm Dis. 2022 Oct 26;9(4):486-499. doi: 10.15326/jcopdf.2022.0305. Chronic Obstr Pulm Dis. 2022. PMID: 35877930 Free PMC article.
-
Comparison of in-person versus telephonic interview on tobacco cessation in an Indian dental setting.Bioinformation. 2023 Jun 30;19(6):775-780. doi: 10.6026/97320630019775. eCollection 2023. Bioinformation. 2023. PMID: 37885778 Free PMC article.
-
A randomized placebo-controlled trial of varenicline for smoking cessation allowing flexible quit dates.Nicotine Tob Res. 2012 Mar;14(3):343-50. doi: 10.1093/ntr/ntr220. Epub 2011 Nov 11. Nicotine Tob Res. 2012. PMID: 22080588 Free PMC article. Clinical Trial.
-
Predicting Success of a Digital Self-Help Intervention for Alcohol and Substance Use With Machine Learning.Front Psychol. 2021 Sep 3;12:734633. doi: 10.3389/fpsyg.2021.734633. eCollection 2021. Front Psychol. 2021. PMID: 34552539 Free PMC article.
References
-
- Abrams DB, Niaura R, Brown RA, Emmons KM, Goldstein MG, Monti PM. A Guide To Best Practices. The Guiford Press; New York, NY: 2003. The Tobacco Dependence Treatment Handbook.
-
- Bandura A. Self-efficacy: Toward a unifying theory of behavior change. Psychol Rev. 1977;84:191–215. - PubMed
-
- Becker K, Rose J, Albino A. A randomized trial of nicotine replacement therapy in combination with reduced-nicotine cigarettes for smoking cessation. Nic Tob Res. 2008;10:1139–1148. - PubMed
-
- Bouton ME, Swartzentruber D. Sources of relapse after extinction in Pavlovian and instrumental learning. Clin Psychol Rev. 1991;11:123–140.
-
- Bullen CR, Howe C, Lin RB, Whittaker R, Walker N, Glover M, McRobbie H, Grigg M, Wallace-Bell M, Laugesen M. Does pre-quitting nicotine replacement therapy improve quitting success compared with usual treatment? Findings from the PQNIQ Trial. SRNT Annual Meeting; Portland Oregon. 2008.
Publication types
MeSH terms
Substances
Associated data
Grants and funding
LinkOut - more resources
Full Text Sources
Medical